IBDEI0QN ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12003,0)
 ;;=90697^^48^589^5^^^^1
 ;;^UTILITY(U,$J,358.3,12003,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12003,1,2,0)
 ;;=2^90697
 ;;^UTILITY(U,$J,358.3,12003,1,3,0)
 ;;=3^DTAP-IPV-HIB-HEPB VACCINE IM
 ;;^UTILITY(U,$J,358.3,12004,0)
 ;;=90625^^48^589^2^^^^1
 ;;^UTILITY(U,$J,358.3,12004,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12004,1,2,0)
 ;;=2^90625
 ;;^UTILITY(U,$J,358.3,12004,1,3,0)
 ;;=3^CHOLERA VACCINE,ORAL
 ;;^UTILITY(U,$J,358.3,12005,0)
 ;;=90620^^48^589^27^^^^1
 ;;^UTILITY(U,$J,358.3,12005,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12005,1,2,0)
 ;;=2^90620
 ;;^UTILITY(U,$J,358.3,12005,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,PROTEIN/OUT MEM IM
 ;;^UTILITY(U,$J,358.3,12006,0)
 ;;=90621^^48^589^26^^^^1
 ;;^UTILITY(U,$J,358.3,12006,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12006,1,2,0)
 ;;=2^90621
 ;;^UTILITY(U,$J,358.3,12006,1,3,0)
 ;;=3^MENINGOCOCCAL VACCINE,LIPOPROTEIN IM
 ;;^UTILITY(U,$J,358.3,12007,0)
 ;;=90686^^48^589^16^^^^1
 ;;^UTILITY(U,$J,358.3,12007,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12007,1,2,0)
 ;;=2^90686
 ;;^UTILITY(U,$J,358.3,12007,1,3,0)
 ;;=3^FLU VACCINE SINGLE DOSE SYR (FLUARIX QUADRIVALENT)
 ;;^UTILITY(U,$J,358.3,12008,0)
 ;;=90674^^48^589^10^^^^1
 ;;^UTILITY(U,$J,358.3,12008,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12008,1,2,0)
 ;;=2^90674
 ;;^UTILITY(U,$J,358.3,12008,1,3,0)
 ;;=3^FLU VACCINE LOW DOSE SYR (FLUCELVAX ccIIV4)
 ;;^UTILITY(U,$J,358.3,12009,0)
 ;;=90672^^48^589^9^^^^1
 ;;^UTILITY(U,$J,358.3,12009,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12009,1,2,0)
 ;;=2^90672
 ;;^UTILITY(U,$J,358.3,12009,1,3,0)
 ;;=3^FLU VACCINE INTRANASAL,QUADRIVALENT,LIVE
 ;;^UTILITY(U,$J,358.3,12010,0)
 ;;=90688^^48^589^12^^^^1
 ;;^UTILITY(U,$J,358.3,12010,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12010,1,2,0)
 ;;=2^90688
 ;;^UTILITY(U,$J,358.3,12010,1,3,0)
 ;;=3^FLU VACCINE MULTI DOSE VL (FLULAVA QUADRIVALENT)
 ;;^UTILITY(U,$J,358.3,12011,0)
 ;;=90682^^48^589^14^^^^1
 ;;^UTILITY(U,$J,358.3,12011,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12011,1,2,0)
 ;;=2^90682
 ;;^UTILITY(U,$J,358.3,12011,1,3,0)
 ;;=3^FLU VACCINE SINGLE DOSE FLUBLOK (RIV4)
 ;;^UTILITY(U,$J,358.3,12012,0)
 ;;=90750^^48^589^40^^^^1
 ;;^UTILITY(U,$J,358.3,12012,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12012,1,2,0)
 ;;=2^90750
 ;;^UTILITY(U,$J,358.3,12012,1,3,0)
 ;;=3^ZOSTER (SHINGLES) VACCINE-IM
 ;;^UTILITY(U,$J,358.3,12013,0)
 ;;=90653^^48^589^13^^^^1
 ;;^UTILITY(U,$J,358.3,12013,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12013,1,2,0)
 ;;=2^90653
 ;;^UTILITY(U,$J,358.3,12013,1,3,0)
 ;;=3^FLU VACCINE SINGLE DOSE (FLUAD SEQIRUS)
 ;;^UTILITY(U,$J,358.3,12014,0)
 ;;=96365^^48^590^7^^^^1
 ;;^UTILITY(U,$J,358.3,12014,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12014,1,2,0)
 ;;=2^96365
 ;;^UTILITY(U,$J,358.3,12014,1,3,0)
 ;;=3^THER/PROPH/DIAG IV INF INIT HR
 ;;^UTILITY(U,$J,358.3,12015,0)
 ;;=96366^^48^590^6^^^^1
 ;;^UTILITY(U,$J,358.3,12015,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12015,1,2,0)
 ;;=2^96366
 ;;^UTILITY(U,$J,358.3,12015,1,3,0)
 ;;=3^THER/PROPH/DIAG IV INF EA ADD HR
 ;;^UTILITY(U,$J,358.3,12016,0)
 ;;=96367^^48^590^8^^^^1
 ;;^UTILITY(U,$J,358.3,12016,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,12016,1,2,0)
 ;;=2^96367
 ;;^UTILITY(U,$J,358.3,12016,1,3,0)
 ;;=3^TX/PROPH/DX IV INF,ADDL SEQ
 ;;^UTILITY(U,$J,358.3,12017,0)
 ;;=96374^^48^590^4^^^^1
 ;;^UTILITY(U,$J,358.3,12017,1,0)
 ;;=^358.31IA^3^2
